Johnson & Johnson recalls 70,000 syringes of the anti-psychotic medication Invega Sustenna nationwide due to the possibility of dangerous cracks that could lead to infections and/or reduced efficacy in users. Consumers are advised to stop using recalled products and discard them immediately. This new recall is the latest in a series of woes for J&J.
Free Case Evaluation: If you or a loved one has suffered any adverse side effects after using a syringe included in this recall, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.
What’s the problem?
February 17, 2011 - This week, a unit of Johnson & Johnson announced that it will be recalling approximately 70,000 Invega Sustenna syringes nationwide due to the possibility of cracks in the vials. This defect could compromise the sterility of the syringe contents and possibly result in local injection-site infections or systemic infections. Leakage of the drug through the crack could result in a lower-than-intended therapeutic dose if the product is administered.
The syringe recall applies to Invega Sustenna (paliperidone palmitate 234 mg) Extended-Release Injectable Suspension with NDC 50458-564-01 and lot numbers:
These products contain expiration dates of:
This recall also affects sample packages with the NDC 50458-564-03 and lot numbers 9JBK000, 9JBK001 and 9IBK000 and expiration dates of 08/2012 and 12/2011. Consumers cannot see cracks or other defects in the syringes because the vials are covered by the label. Click here  to learn more about Invega.
This recall is just the latest in a long series of woes for Johnson & Johnson, who has issued numerous massive recalls in the past 18 months on products ranging from Tylenol and Motrin to contact lenses and hip replacement parts. The recalls have taken a huge hit on overall sales, as well as damaged the reputation of the pharmaceutical giant. J&J has said it is taking steps to improve quality, including the renovation of an over-the-counter medicine manufacturing plant outside Philadelphia.
What is the Invega Syringe?
Invega injections are used to treat schizophrenia, a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions. Invega is administered by injection into a muscle (upper arm or buttocks) by a healthcare professional.
The first 2 doses of Invega are typically given 1 week apart, in the upper arm. After the first 2 doses, Invega is usually given into the upper arm or buttocks every month or as directed by your healthcare provider.
What's the Difference Between Invega and Invega Sustenna?
The difference between Invega Sustenna, Invega Trinza, and Invega Hayfera is how long the drugs last in the body. Invega Sustenna lasts for 1 month, Invega Trinza lasts for 3 months, and Invega Hayfera lasts for 6 months and only needs to be given twice a year.
- Medical Device Attorneys & Lawsuits Info
- HawkOne Directional Atherectomy System Litigation
- Endotracheal Tube Lawsuit
See all related product liability lawsuits our attorneys covered so far.
Do I have an Invega Syringe Recall Lawsuit?
The Product Liability Litigation Group at Schmidt & Clark, LLP law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Invega Syringe Recall lawsuits. We are handling individual litigation nationwide and are currently accepting new infection & reduced efficacy cases in all 50 states.